<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">128</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2011-7-2-22</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак почки</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="ru">К О М М Е Н Т А Р И Й К СТАТЬЕ Ф.Р. ДЖАБАРОВА И СОАВТ. «РОЛЬ АДЪЮВАНТНОЙ ГАММА-ТЕРАПИИ В ЛЕЧЕНИИ РАКА ПОЧКИ»</article-title><trans-title-group xml:lang="en"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Волкова</surname><given-names>М. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2011-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2011</year></pub-date><volume>7</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><history><date date-type="received" iso-8601-date="2014-07-27"><day>27</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-27"><day>27</day><month>07</month><year>2014</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/128">https://oncourology.abvpress.ru/oncur/article/view/128</self-uri><abstract xml:lang="ru"><p>Комментарий к статье Ф.Р. Джабарова и соавт. «Роль адъювантной гамма-терапиив лечении рака почки».</p></abstract><trans-abstract xml:lang="en"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>комментарий</kwd><kwd>статья</kwd><kwd>рак почки</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Kjaer M., Frederiksen P.L., Engelholm S.A. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study group. Int J Radiat Oncol Biol Phys 1987;13(5):665–72.</mixed-citation><mixed-citation xml:lang="ru">Kjaer M., Frederiksen P.L., Engelholm S.A. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study group. Int J Radiat Oncol Biol Phys 1987;13(5):665–72.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Makarewicz R., Zarzycka M., Kulinska G., Windorbska W. The value of post-operative radiotherapy in advanced renal cell carcinoma. Neoplasma 1998;45:380–3.</mixed-citation><mixed-citation xml:lang="ru">Makarewicz R., Zarzycka M., Kulinska G., Windorbska W. The value of post-operative radiotherapy in advanced renal cell carcinoma. Neoplasma 1998;45:380–3.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Джабаров Ф.Р., Шевченко А.Н., Розенко Л.Я. Роль адъювантной гамма-терапии в лечении рака почки. Онкоурология 2011;(1):16–9.</mixed-citation><mixed-citation xml:lang="ru">Джабаров Ф.Р., Шевченко А.Н., Розенко Л.Я. Роль адъювантной гамма-терапии в лечении рака почки. Онкоурология 2011;(1):16–9.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Yagoda A., Abi-Rached B., Petrylak D. Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin Oncol 1995;22(1):42–60.</mixed-citation><mixed-citation xml:lang="ru">Yagoda A., Abi-Rached B., Petrylak D. Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin Oncol 1995;22(1):42–60.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Ulutin H.C., Aksu G., Fayda M. et al. The value of postoperative radiotherapy in renal cell carcinoma: a single institution experience. Tumori 2006;92:202–6.</mixed-citation><mixed-citation xml:lang="ru">Ulutin H.C., Aksu G., Fayda M. et al. The value of postoperative radiotherapy in renal cell carcinoma: a single institution experience. Tumori 2006;92:202–6.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Gofrit O.N., Shapiro A., Pizov G. et al. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? J Urol 2007;177:1682–6.</mixed-citation><mixed-citation xml:lang="ru">Gofrit O.N., Shapiro A., Pizov G. et al. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? J Urol 2007;177:1682–6.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Yoo C., Song C., Hong J.H. et al. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. J Urol 2008;180:486–91.</mixed-citation><mixed-citation xml:lang="ru">Yoo C., Song C., Hong J.H. et al. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. J Urol 2008;180:486–91.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Finney R. The value of radiotherapy in the treatment of hypernephroma: a clinical trial. Br J Urol 1973;45:258–69.</mixed-citation><mixed-citation xml:lang="ru">Finney R. The value of radiotherapy in the treatment of hypernephroma: a clinical trial. Br J Urol 1973;45:258–69.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Kao G., Malkowicz S.B., Whittington R. et al. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy with CT. Radiology 1994;193:725–30.</mixed-citation><mixed-citation xml:lang="ru">Kao G., Malkowicz S.B., Whittington R. et al. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy with CT. Radiology 1994;193:725–30.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Stein M., Kuten A., Halpern J. et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol 1992;24:41–4.</mixed-citation><mixed-citation xml:lang="ru">Stein M., Kuten A., Halpern J. et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol 1992;24:41–4.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Rafla S., Parikh K. The role of adjuvant radiotherapy in the management of renal cell carcinoma. In: N. Javadpour (ed.). Cancer of the Kidney. New York, NY: Thieme-Stratton, 1984.</mixed-citation><mixed-citation xml:lang="ru">Rafla S., Parikh K. The role of adjuvant radiotherapy in the management of renal cell carcinoma. In: N. Javadpour (ed.). Cancer of the Kidney. New York, NY: Thieme-Stratton, 1984.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Zhang B.X. Postoperative radiotherapy of renal carcinoma: analysis of 57 patients. Zhonghua Zhong Liu Za Zhi 1991;13:223–5.</mixed-citation><mixed-citation xml:lang="ru">Zhang B.X. Postoperative radiotherapy of renal carcinoma: analysis of 57 patients. Zhonghua Zhong Liu Za Zhi 1991;13:223–5.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Tunio M. A., Hashmi A. &amp; Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol 2010;21:1839–45.</mixed-citation><mixed-citation xml:lang="ru">Tunio M. A., Hashmi A. &amp; Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol 2010;21:1839–45.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
